The Prevalence of Nontherapeutic and Dangerous International Normalized Ratios Among Patients Receiving Warfarin in the Emergency Department

Annals of Emergency Medicine

Volumn 48, Issue 2, 2006, Pages

  Newman, David H ^a   Zhitomirsky, Inna ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; WARFARIN;

AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; EMERGENCY WARD; EPISTAXIS; FEMALE; HEMATOMA; HEMATURIA; HEMOPTYSIS; HEMORRHOID HEMORRHAGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PLASMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGRESSION ANALYSIS; VAGINA BLEEDING; VENOUS THROMBOEMBOLISM;

ACADEMIC MEDICAL CENTERS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DECISION SUPPORT TECHNIQUES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICAL AUDIT; MEDICAL HISTORY TAKING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; WARFARIN;

EID: 33745969106     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2005.12.010     Document Type: Article

References (34)

1. Schulman S. Clinical practice. care of patients receiving long-term anticoagulant therapy. N Engl J Med. 349 (2003) 675-683
2. Allen E., Barker N., and Waugh J. A preparation from spoiled sweet clover: [3.3'-methylene-bis-(4-hydroxycoumarin)] which prolongs coagulation and prothrombin time of the blood: a clinical study. JAMA 120 (1942) 1009-1015
3. Seabrook G., Karp D., Schmitt D., et al. An outpatient anticoagulation protocol managed by a vascular nurse-clinician. Am J Surg. 160 (1990) 501-505
4. Cannegieter S., Rosendaal F., Wintzen A., et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 333 (1995) 11-17
5. Garabedian-Ruffalo S., Gray D., Sax M., et al. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm. 42 (1985) 304-308
6. Chiquette E., Amato M., and Bussey H. Comparison of anticoagulation clinic with usual medical care. anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 158 (1998) 1641-1647
7. Pell J., and Alcock J. Monitoring anticoagulant control in general practice. comparison of management in areas with and without access to hospital anticoagulant. Br J Gen Pract. 44 (1994) 357-358
8. Chamberlain M., Sageser N., and Ruiz D. Comparison of anticoagulation clinic outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract. 14 (2001) 16-21
9. Holden J., and Holden K. Comparative effectiveness of general practitioner versus pharmacist dosing of patients requiring anticoagulation in the community. J Clin Pharmacol Ther. 25 (2000) 49-54
10. White R., Hong R., Venook A., et al. Initiation of warfarin therapy. comparison of physician dosing with computer-assisted dosing. J Gen Intern Med. 2 (1987) 141-148
11. White R., McCurdy S., von Marensdorff H., et al. Home prothrombin time monitoring after the initiation of warfarin therapy. a randomized, prospective study. Ann Intern Med. 111 (1989) 730-737
12. Ansell J., Patel N., Ostrovsky D., et al. Long-term patient self-management of oral anticoagulation. Arch Intern Med. 155 (1997) 2185-2189
13. Gottlieb L., and Salem-Schatz S. Anticoagulation in atrial fibrillation. does efficacy in clinical trials translate into effectiveness in practice?. Arch Intern Med. 154 (1994) 1945-1953
14. Sawicki P. A structured teaching and self-management program for patients receiving oral anticoagulation. a randomized controlled trial. JAMA 281 (1999) 145-150
15. Hylek E., and Singer D. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 120 (1994) 897-902
16. Levine M., Raskob G., Landefeld C., et al. Hemorrhagic complications of anticoagulant treatment. Chest 119 (2001) 108S-121S
17. Oden A., and Fahlen M. Oral anticoagulation and risk of death. a medical record linkage study. BMJ 325 (2002) 1073-1075
18. Hylek E., Go A., Chang Y., et al. The effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 349 (2003) 1019-1026
19. Rosand J., Eckman M., Knudsen K., et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 164 (2004) 880-884
20. Hyers T., Agnelli G., Hull R., et al. Antithrombotic therapy for venous thromboembolic disease. Chest 114 (1998) 561S-578S
21. Albers G., Dalen G., Laupacis A., et al. Antithrombotic therapy in atrial fibrillation. Chest 119 (2001) 194S-206S
22. Salem D., Daudelin H., Levine H., et al. Antithrombotic therapy in valvular heart disease. Chest 119 (2001) 207S-219S
23. Stein P., Alpert J., Bussey H., et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 119 (2001) 220S-227S
24. Bonow R., Carabello B., de Leon A., et al. Guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 98 (1998) 1949-1984
25. Hirsh J., Fuster V., Ansell J., et al. America Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 107 (2003) 1692-1711
26. Khamashta M., Cuadrado M., Mujic F., et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med. 332 (1995) 993-997
27. Palareti G., Leali N., Coccheri S., et al. Bleeding complications of oral anticoagulant treatment. an inception-cohort, prospective collaborative study (ISCOAT). Lancet 348 (1996) 423-428
28. Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol. 42 (1997) 857-865
29. Kearon C., Ginsberg J., Kovacs M., et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med. 349 (2003) 631-639
30. Paneerselvam S., Baglin C., Lefort W., et al. Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin. Br J Haematol. 103 (1998) 422-424
31. Crowther M., Ginsberg J., Julian J., et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 349 (2003) 1133-1138
32. Cetta M., Asplin B., Fields W., et al. Emergency medicine and the debate over the uninsured. a report from the Task Force on Health Care and the Uninsured. Ann Emerg Med. 36 (2000) 243-246
33. Lewin M., and Altman S. Background and overview. America's Health Care Safety Net. Intact but Endangered (2000), Institute of Medicine, Washington, DC 16-46
34. Ansell J., Buttaro M., Thomas O., et al. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force. Ann Pharmacother. 31 (1997) 604-615